We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Biosynth Carbosynth and Shengquan Acquire New Plant to Increase Production Capacities in China
Product News

Biosynth Carbosynth and Shengquan Acquire New Plant to Increase Production Capacities in China

Biosynth Carbosynth and Shengquan Acquire New Plant to Increase Production Capacities in China
Product News

Biosynth Carbosynth and Shengquan Acquire New Plant to Increase Production Capacities in China


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Biosynth Carbosynth and Shengquan Acquire New Plant to Increase Production Capacities in China"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Biosynth Carbosynth, a leading life sciences reagents and custom synthesis and manufacturing services company, and JINAN SHENGQUAN GROUP SHARE-HOLDING CO., LTD. announced their acquisition of Kexing Biopharmaceutical Co., Ltd’s raw material factory in Jinan, China. With this acquisition, Biosynth Carbosynth’s and Shengquan’s joint venture Carbotang expands the production capacities significantly. The more than 30,000 square meter property contains a comprehensive factory building on 5 floors, a demo workshop and a large warehouse including a state-of-the-art dangerous material storage. The expansion through a further production site now allows the group more flexibility and larger production volumes together with an increased production reliability. This is an essential prerequisite in the production of Biosynth Carbosynth’s products.

Dr. Urs Spitz, CEO of Biosynth Carbosynth said “We are delighted to be further expanding our manufacturing operations and hugely successful joint venture. With this strategic acquisition we can continue to deliver our enormous range of products at increasing scales, with unrivalled expertise in complex organic chemistries.”

  

Advertisement